Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Avian scavengers and the threat from veterinary pharmaceuticals.
Cuthbert RJ, Taggart MA, Prakash V, Chakraborty SS, Deori P, Galligan T, Kulkarni M, Ranade S, Saini M, Sharma AK, Shringarpure R, Green RE. Cuthbert RJ, et al. Among authors: shringarpure r. Philos Trans R Soc Lond B Biol Sci. 2014 Nov 19;369(1656):20130574. doi: 10.1098/rstb.2013.0574. Philos Trans R Soc Lond B Biol Sci. 2014. PMID: 25405963 Free PMC article.
Experimental safety testing shows that the NSAID tolfenamic acid is not toxic to Gyps vultures in India at concentrations likely to be encountered in cattle carcasses.
Chandramohan S, Mallord JW, Mathesh K, Sharma AK, Mahendran K, Kesavan M, Gupta R, Chutia K, Pawde A, Prakash NV, Ravichandran P, Saikia D, Shringarpure R, Timung A, Galligan TH, Green RE, Prakash VM. Chandramohan S, et al. Among authors: shringarpure r. Sci Total Environ. 2022 Feb 25;809:152088. doi: 10.1016/j.scitotenv.2021.152088. Epub 2021 Nov 30. Sci Total Environ. 2022. PMID: 34861305
Metabolism of aceclofenac to diclofenac in the domestic water buffalo Bubalus bubalis confirms it as a threat to Critically Endangered Gyps vultures in South Asia.
Chandramohan S, Mathesh K, Mallord JW, Naidoo V, Mahendran K, Kesavan M, Gaur GK, Pawde AM, Prakash N, Ranade S, Saikia D, Sharma AK, Shringarpure R, Green RE, Prakash VM. Chandramohan S, et al. Among authors: shringarpure r. Environ Toxicol Pharmacol. 2022 Nov;96:103984. doi: 10.1016/j.etap.2022.103984. Epub 2022 Sep 28. Environ Toxicol Pharmacol. 2022. PMID: 36182041
Experimental safety testing confirms that the NSAID nimesulide is toxic to Gyps vultures in India.
Mathesh K, Manickam K, Mallord JW, Mahendran K, Kumar M A, Saikia D, Mohan S C, V B, Lakshmi P S, Prakash N, Shringarpure R, Pawde AM, Green RE, Naidoo V, Prakash V. Mathesh K, et al. Among authors: shringarpure r. Environ Toxicol Pharmacol. 2023 Oct;103:104284. doi: 10.1016/j.etap.2023.104284. Epub 2023 Sep 27. Environ Toxicol Pharmacol. 2023. PMID: 37775075
Retraction: Insulin-like Growth Factor-1 Induces Adhesion and Migration in Human Multiple Myeloma Cells via Activation of β1-Integrin and Phosphatidylinositol 3'-Kinase/AKT Signaling.
Tai YT, Podar K, Catley L, Tseng YH, Akiyama M, Shringarpure R, Burger R, Hideshima T, Chauhan D, Mitsiades N, Richardson P, Munshi NC, Kahn CR, Mitsiades C, Anderson KC. Tai YT, et al. Among authors: shringarpure r. Cancer Res. 2024 Mar 15;84(6):938. doi: 10.1158/0008-5472.CAN-24-0519. Cancer Res. 2024. PMID: 38486484 No abstract available.
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study.
Harrison SA, Frias JP, Lucas KJ, Reiss G, Neff G, Bollepalli S, Su Y, Chan D, Tillman EJ, Moulton A, de Temple B, Zari A, Shringarpure R, Rolph T, Cheng A, Yale K. Harrison SA, et al. Among authors: shringarpure r. Clin Gastroenterol Hepatol. 2024 Mar 4:S1542-3565(24)00226-X. doi: 10.1016/j.cgh.2024.02.022. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38447814 Free article.
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.
Harrison SA, Frias JP, Neff G, Abrams GA, Lucas KJ, Sanchez W, Gogia S, Sheikh MY, Behling C, Bedossa P, Shao L, Chan D, Fong E, de Temple B, Shringarpure R, Tillman EJ, Rolph T, Cheng A, Yale K; HARMONY Study Group. Harrison SA, et al. Among authors: shringarpure r. Lancet Gastroenterol Hepatol. 2023 Dec;8(12):1080-1093. doi: 10.1016/S2468-1253(23)00272-8. Epub 2023 Oct 3. Lancet Gastroenterol Hepatol. 2023. PMID: 37802088 Clinical Trial.
A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.
Harrison SA, Ruane PJ, Freilich B, Neff G, Patil R, Behling C, Hu C, Shringarpure R, de Temple B, Fong E, Tillman EJ, Rolph T, Cheng A, Yale K. Harrison SA, et al. Among authors: shringarpure r. JHEP Rep. 2022 Aug 23;5(1):100563. doi: 10.1016/j.jhepr.2022.100563. eCollection 2023 Jan. JHEP Rep. 2022. PMID: 36644237 Free PMC article.
51 results